Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has submitted a routine compliance certificate to BSE for the quarter ended September 30, 2025. The certificate, issued by the company's Registrar and Transfer Agent (Beetal Financial & Computer Services Pvt Ltd) on October 7, 2025, confirms that all physical share certificates received from Depository Participants for dematting during Q2 FY26 were processed, confirmed to the depositories, mutilated, and cancelled. The names of the depositories have been substituted as the registered owners in the company's register of members within the required 15-day timeframe. This is a standard quarterly regulatory filing with no business or financial content.
This is a routine procedural filing required under SEBI depositary regulations and has no material impact on the company's operations, financials, or stock price. It merely reaffirms that the company's share dematerialization process is functioning normally.